tirzepatide phase 3 Lilly's Reduced Heart Failure and Obesity Symptoms in Trial Lilly's tirzepatide lowers risk of

L-carnitine supplements are taken by mouth to increase L-carnitine levels in people whose natural level of L-carnitine is too low because they have a genetic disorder, are taking certain drugs (such as valproic acid for seizures or certain antibiotics for tuberculosis), or because they are undergoing a medical procedure (hemodialysis for kidney disease) that uses up the body's L-carnitine

Long-Term Safety Data Emerging Signals As more patients use GLP-1 agonists over extended periods, new concerns are emerging around long-term health effects

People with type 1 diabetes also need to keep taking their insulin to avoid diabetic ketoacidosis (DKA), when insulin levels are too low

More people are turning to GLP-1 medications to lose weight and manage chronic conditions